These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27179908)
21. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. Fride E Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678 [TBL] [Abstract][Full Text] [Related]
22. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice. Haller VL; Cichewicz DL; Welch SP Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265 [TBL] [Abstract][Full Text] [Related]
23. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core. Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307 [TBL] [Abstract][Full Text] [Related]
24. Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade. Crespillo A; Suárez J; Bermúdez-Silva FJ; Rivera P; Vida M; Alonso M; Palomino A; Lucena MA; Serrano A; Pérez-Martín M; Macias M; Fernández-Llébrez P; Rodríguez de Fonseca F Biochem J; 2011 Jan; 433(1):175-85. PubMed ID: 20955176 [TBL] [Abstract][Full Text] [Related]
25. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Pertwee RG Life Sci; 2005 Feb; 76(12):1307-24. PubMed ID: 15670612 [TBL] [Abstract][Full Text] [Related]
26. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Kearn CS; Blake-Palmer K; Daniel E; Mackie K; Glass M Mol Pharmacol; 2005 May; 67(5):1697-704. PubMed ID: 15710746 [TBL] [Abstract][Full Text] [Related]
27. Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice. Ostadhadi S; Haj-Mirzaian A; Nikoui V; Kordjazy N; Dehpour AR Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):203-12. PubMed ID: 26609670 [TBL] [Abstract][Full Text] [Related]
30. Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~let-7d in glioblastoma. Wang Z; Lin S; Zhang J; Xu Z; Xiang Y; Yao H; Ge L; Xie D; Kung HF; Lu G; Poon WS; Liu Q; Lin MC Oncotarget; 2016 Aug; 7(35):56266-56278. PubMed ID: 27409345 [TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death. Tomiyama K; Funada M Toxicol Appl Pharmacol; 2014 Jan; 274(1):17-23. PubMed ID: 24211273 [TBL] [Abstract][Full Text] [Related]
32. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432 [TBL] [Abstract][Full Text] [Related]
33. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131 [TBL] [Abstract][Full Text] [Related]
34. Cannabinoids and the human uterus during pregnancy. Dennedy MC; Friel AM; Houlihan DD; Broderick VM; Smith T; Morrison JJ Am J Obstet Gynecol; 2004 Jan; 190(1):2-9; discussion 3A. PubMed ID: 14749627 [TBL] [Abstract][Full Text] [Related]
36. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence. Trang T; Ma W; Chabot JG; Quirion R; Jhamandas K Pain; 2006 Dec; 126(1-3):256-71. PubMed ID: 16935424 [TBL] [Abstract][Full Text] [Related]
37. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778 [TBL] [Abstract][Full Text] [Related]
38. Let-7d microRNA Attenuates 6-OHDA-Induced Injury by Targeting Caspase-3 in MN9D Cells. Li L; Liu H; Song H; Qin Y; Wang Y; Xu M; Liu C; Gao J; Sun S J Mol Neurosci; 2017 Dec; 63(3-4):403-411. PubMed ID: 29082467 [TBL] [Abstract][Full Text] [Related]
39. MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1~let-7d via noncanonical E-box. Wang Z; Lin S; Li JJ; Xu Z; Yao H; Zhu X; Xie D; Shen Z; Sze J; Li K; Lu G; Chan DT; Poon WS; Kung HF; Lin MC J Biol Chem; 2011 Nov; 286(46):39703-14. PubMed ID: 21903590 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA let-7d regulates the TLX/microRNA-9 cascade to control neural cell fate and neurogenesis. Zhao C; Sun G; Ye P; Li S; Shi Y Sci Rep; 2013; 3():1329. PubMed ID: 23435502 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]